...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Array and Zenith

Thanks.  Love your viewpoint.

My main point was that Array was much farther along with more trials than Zenith.

Share
New Message
Please login to post a reply